home All News open_in_new Full Article

Pharmaindustrie: Bayer stärkt Forschung an Krebsmedikamenten mit Zukauf in China

Nach Deals von Merck und Novo Nordisk kauft nun auch Bayer in China zu. Ein neues Medikament soll Patienten mit bestimmten Krebsarten helfen.


today 3 d. ago attach_file Society

attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics
attach_file Society
attach_file Politics
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Society


ID: 771426197
Add Watch Country

arrow_drop_down